The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Ligand and Target Discovery by Fragment-Based Screening in Human Cells
Open accessAbstract
Advances in the synthesis and screening of small-molecule libraries have accelerated the discovery of chemical probes for studying biological processes. Still, only a small fraction of the human proteome has chemical ligands. Here, we describe a platform that marries fragment-based ligand discovery with quantitative chemical proteomics to map thousands of reversible small molecule-protein interactions directly in human cells, many of which can be site-specifically determined. We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chemical probes. We further combine fragment-based chemical proteomics with phenotypic screening to identify small molecules that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2. Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small molecules and their molecular targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Equipping noncovalent fragments with a photoreactive diazirine moiety similarly enables their proteome-wide target identification without the prerequisite of a particular amino acid in or nearby a ligandable site.98−100”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [98]
In the citing paper
“We recently introduced a strategy that integrates FBLD with chemical proteomics to globally assess small molecule-protein interactions in human cells13.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“As a consequence, we found that individual FFF probes showed substantial differences in their overall proteomic interaction profiles, which made for complicated structure-activity relationships (SARs) requiring careful manual review to identify fragment-protein interactions that reflected authentic recognition events (versus simply correlating with the overall proteomic interaction profiles of the”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“Moreover, while many of the enantioprobe targets were also enriched by members of the original FFF probe set13, these previous profiles often did not provide useful SAR information, either reflecting substantial enrichment by all of the FFF probes or mirroring the respective global protein interaction footprints of these probes (Supplementary Fig. 2).”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“Nonetheless, we also found that individual FFFs showed substantially different overall protein interaction profiles in human cells, which complicated the assignment of small molecule-protein interactions displaying authentic SARs (vs nonspecific binding to the FFFs).”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“The initial set of fully functionalized (clickable, photoreactive) fragments (FFFs) uncovered many new small molecule-protein interactions, some of which were advanced to selective and cell-active chemical probes.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“We previously described a chemical proteomic strategy to perform fragment-based ligand discovery experiments in human cells13.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
Washburn, M. P., Wolters, D. A., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,768
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Computational Methods in Drug Discovery
Sliwoski, G. R., Kothiwale, S., Meiler, J., & Lowe, E. W. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,306
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 2,002
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Fpocket: An open source platform for ligand pocket detection
Guilloux, V. L., Schmidtke, P., & Tufféry, P. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-168 · Cited by 1,724
Quantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684
Self-citationPrivileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302
Research works printed but not linked: 1
- Gerdes, 1998, Cloning and tissue expression of two putative steroid membrane receptors, Biol. Chem., 379, 907
Cited by
Sorted by citations
Items 101–200 of 445
Chemoproteomics, A Broad Avenue to Target Deconvolution
Gao, Y., Ma, M., Li, W., & Lei, X. (2023) · Advanced Science · doi:10.1002/advs.202305608 · Cited by 54
Photoaffinity labelling with small molecules
Homan, R. A., Lapek, J. D., Woo, C. M., Niessen, S., Jones, L. H., & Parker, C. G. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00308-4 · Cited by 60
Self-citationLead-like Drugs: A Perspective
Raymer, B. K., & Bhattacharya, S. K. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00407 · Cited by 52
Zhou, W., Chen, M., Liu, H.-L., Si, Z.-L., Wu, W., Jiang, H., Wang, L.-X., Vaziri, N. D., An, X., Su, K., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00898-3 · Cited by 51
Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments
Aatkar, A., Vuorinen, A., Longfield, O., Gilbert, K. E., Heap, R. E., Wagner, C. D., Zappacosta, F., Rittinger, K., Chung, C., House, D., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00034 · Cited by 51
Flaxman, H. A., Chang, C., Wu, H., Nakamoto, C. H., & Woo, C. M. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03764 · Cited by 51
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11098 · Cited by 50
Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation
Ruffilli, C., Röth, S., Rodrigo, M., Boyd, H., Zelcer, N., & Moreau, K. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00142 · Cited by 51
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
McAulay, K., Bilsland, A. E., & Bon, M. (2022) · Pharmaceuticals · doi:10.3390/ph15111366 · Cited by 54
Joshi, A., Shaikh, M., Singh, S., Rajendran, A., Mhetre, A. B., & Kamat, S. S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005640 · Cited by 49
Multiplexed CuAAC Suzuki–Miyaura Labeling for Tandem Activity-Based Chemoproteomic Profiling
Cao, J. X., Boatner, L. M., Desai, H. S., Burton, N. R., Armenta, E., Chan, N. J., Castellón, J. O., & Backus, K. M. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04726 · Cited by 48
Classical and Non-Classical Progesterone Signaling in Breast Cancers
Pedroza, D. A., Subramani, R., & Lakshmanaswamy, R. (2020) · Cancers · doi:10.3390/cancers12092440 · Cited by 48
Target Validation Using PROTACs: Applying the Four Pillars Framework
Nowak, R. P., & Jones, L. H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220979584 · Cited by 48
Gonzalez-Valero, A., Reeves, A. G., Page, A. C. S., Moon, P. J., Miller, E., Coulonval, K., Crossley, S. W. M., Xie, X., He, D., Musacchio, P. Z., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c04039 · Cited by 47
Du, H., Zhou, Y., Suo, Y., Xiao, L., Chai, B., Duan, R., Huang, X., & Li, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.001 · Cited by 46
Photocrosslinking probes for capture of carbohydrate interactions
Wu, H., & Kohler, J. J. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.09.002 · Cited by 47
Thejer, B. M., Adhikary, P. P., Kaur, A., Teakel, S. L., Oosterum, A. V., Seth, I., Pajic, M., Hannan, K. M., Pavy, M., Poh, P., et al. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00256-3 · Cited by 48
Chemically Programmable and Switchable CAR‐T Therapy
Qi, J., Tsuji, K., Hymel, D., Burke, T. R., Hudecek, M., Rader, C. M., & Peng, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005432 · Cited by 45
An update of label-free protein target identification methods for natural active products
Cui, Z., Li, C., Chen, P., & Yang, H. (2022) · Theranostics · doi:10.7150/thno.68804 · Cited by 45
Tallon, A. M., Xu, Y., West, G. M., am Ende, C. W., & Fox, J. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04444 · Cited by 43
Nucleophilic covalent ligand discovery for the cysteine redoxome
Fu, L., Jung, Y., Tian, C., Ferreira, R. B., Cheng, R., He, F., Yang, J. H., & Carroll, K. S. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01330-5 · Cited by 46
Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity
Chiu, T.-Y., Lazar, D. C., Wang, W., Wozniak, J. M., Jadhav, A. M., Li, W., Gazaniga, N. R., Theofilopoulos, A. N., Teijaro, J. R., & Parker, C. G. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01527-8 · Cited by 44
Self-citationZhu, D., Guo, H., Chang, Y., Ni, Y., Li, L., Zhang, Z., Hao, P., Xu, Y., Ding, K., & Li, Z. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802003 · Cited by 43
Valeur, E., & Jimonet, P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00378 · Cited by 43
Target Identification of Bioactive Covalently Acting Natural Products
Nomura, D. K., & Maimone, T. J. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_121 · Cited by 44
Chemoproteomic profiling of protein–metabolite interactions
Qin, W., Yang, F., & Wang, C. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.11.003 · Cited by 44
Development of Photolenalidomide for Cellular Target Identification
Lin, Z., Amako, Y., Kabir, F., Flaxman, H. A., Budnik, B., & Woo, C. M. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c11920 · Cited by 44
A Chemical Proteomic Map of Heme–Protein Interactions
Homan, R. A., Jadhav, A. M., Conway, L. P., & Parker, C. G. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c06104 · Cited by 43
Self-citationDesign and Evaluation of a Cyclobutane Diazirine Alkyne Tag for Photoaffinity Labeling in Cells
West, A. V., Amako, Y., & Woo, C. M. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c08257 · Cited by 44
Covalent binders in drug discovery
Vasudevan, A., Argiriadi, M. A., Baranczak, A., Friedman, M., Gavrilyuk, J. I., Hobson, A. D., Hulce, J. J., Osman, S., & Wilson, N. S. (2019) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2018.12.002 · Cited by 43
Walking a tightrope: drug discovery in visceral leishmaniasis
Balaña‐Fouce, R., Pérez-Pertejo, M. Y., Domínguez-Asenjo, B., Gutiérrez-Corbo, C., & Reguera, R. M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.007 · Cited by 42
Development and biological applications of sulfur–triazole exchange (SuTEx) chemistry
Borne, A. L., Brulet, J. W., Yuan, K., & Hsu, K. (2021) · RSC Chemical Biology · doi:10.1039/d0cb00180e · Cited by 43
Enhanced mapping of small-molecule binding sites in cells
Wozniak, J. M., Li, W., Governa, P., Chen, L., Jadhav, A. M., Dongré, A. R., Forli, S., & Parker, C. G. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01514-z · Cited by 46
Self-citationApplications of Activity‐Based Protein Profiling (ABPP) and Bioimaging in Drug Discovery
Xu, J., Li, X., Ding, K., & Li, Z. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201901500 · Cited by 41
Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes
Huang, T., Hosseinibarkooie, S., Borne, A. L., Granade, M. E., Brulet, J. W., Harris, T. E., Ferris, H. A., & Hsu, K. (2021) · Chemical Science · doi:10.1039/d0sc06623k · Cited by 42
Rimann, I., González‐Quintial, R., Baccalà, R., Kiosses, W. B., Teijaro, J. R., Parker, C. G., Li, X., Beutler, B., Kono, D. H., & Theofilopoulos, A. N. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200544119 · Cited by 41
Self-citationCarbery, A., Skyner, R., von Delft, F., & Deane, C. M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01004 · Cited by 41
Targeting allosteric regulation of cancer metabolism
Kremer, D. M., & Lyssiotis, C. A. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-00997-6 · Cited by 43
Fragment‐Based Drug Discovery for RNA Targets
Lundquist, K. P., Panchal, V. N., Gotfredsen, C. H., Brenk, R., & Clausen, M. H. (2021) · ChemMedChem · doi:10.1002/cmdc.202100324 · Cited by 40
Wang, Y., Zhao, J., Xu, Y., Tao, C., Tong, J., Luo, Y., Chen, Y., Liu, X., & Xu, T. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102930 · Cited by 39
Self-citationProteomics and Beyond: Cell Decision-Making Shaped by Reactive Electrophiles
Liu, X., Long, M. J. C., & Aye, Y. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.09.014 · Cited by 39
Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders
Liu, Z., Remsberg, J. R., Li, H., Njomen, E., DeMeester, K. E., Tao, Y., Xia, G., Hayward, R. E., Yoo, M., Nguyen, T., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c13448 · Cited by 37
Self-citationPhotoaffinity Labeling Chemistries Used to Map Biomolecular Interactions
West, A. V., & Woo, C. M. (2022) · Israel Journal of Chemistry · doi:10.1002/ijch.202200081 · Cited by 42
Progress of potential drugs targeted in lipid metabolism research
Liang, K., & Dai, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1067652 · Cited by 37
Wilson, D. M., Deacon, A. M., Duncton, M. A. J., Pellicena, P., Georgiadis, M. M., Yeh, A., Arvai, A. S., Moiani, D., Tainer, J. A., & Das, D. (2020) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2020.10.005 · Cited by 37
Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs
Khandelwal, N., Shaikh, M., Mhetre, A. B., Singh, S., Sajeevan, T., Joshi, A., Balaji, K. N., Chakrapani, H., & Kamat, S. S. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.008 · Cited by 35
Ogasawara, D., Konrad, D. B., Tan, Z. Y., Carey, K. L., Luo, J., Won, S. J., Li, H., Carter, T. R., DeMeester, K. E., Njomen, E., et al. (2024) · Cell Chemical Biology · doi:10.1016/j.chembiol.2024.10.005 · Cited by 31
Self-citationA Photoaffinity Displacement Assay and Probes to Study the Cyclin‐Dependent Kinase Family
Grant, E. K., Fallon, D. J., Eberl, H. C., Fantom, K. G. M., Zappacosta, F., Messenger, C., Tomkinson, N. C. O., & Bush, J. T. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201906321 · Cited by 34
Selective Modulation of Dynamic Protein Complexes
Garlick, J. M., & Mapp, A. K. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.07.019 · Cited by 39
PGRMC1: An enigmatic heme-binding protein
McGuire, M. R., & Espenshade, P. J. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108326 · Cited by 37
Holenz, J., & Stoy, P. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.12.001 · Cited by 34
A Sos proteomimetic as a pan-Ras inhibitor
Hong, S. H., Yoo, D. Y., Conway, L. P., Richards-Corke, K. C., Parker, C. G., & Arora, P. S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101027118 · Cited by 35
Self-citationStructural and functional annotation of solute carrier transporters: implication for drug discovery
Dvorak, V., & Superti‐Furga, G. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2244760 · Cited by 34
Proteome-wide mapping of PQS-interacting proteins in Pseudomonas aeruginosa
Dandela, R., Mantin, D., Cravatt, B. F., Rayó, J., & Meijler, M. M. (2018) · Chemical Science · doi:10.1039/c7sc04287f · Cited by 33
Self-citationBartholow, T. G., Burroughs, P. W. W., Elledge, S. K., Byrnes, J. R., Kirkemo, L. L., Garda, V., Leung, K. K., & Wells, J. A. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01473 · Cited by 32
Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics
Lum, K. M., Sato, Y., Beyer, B. A., Plaisted, W. C., Anglin, J. L., Lairson, L. L., & Cravatt, B. F. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00581 · Cited by 31
Self-citationChemical Probes for Understudied Kinases: Challenges and Opportunities
Serafim, R. A. M., Elkins, J. M., Zuercher, W. J., Laufer, S., & Gehringer, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00980 · Cited by 32
Activity‐Based Protein Profiling – Finding General Solutions to Specific Problems
Cravatt, B. F. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202300029 · Cited by 31
Self-citationProteome‐Wide Fragment‐Based Ligand and Target Discovery
Forrest, I., & Parker, C. G. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200098 · Cited by 31
Self-citationRational Design Strategies in DNA‐Encoded Libraries for Drug Discovery
Wang, X., Li, L., Shen, X., & Lu, X. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202511839 · Cited by 31
Guo, H., Xu, J., Hao, P., Ding, K., & Li, Z. (2017) · Chemical Communications · doi:10.1039/c7cc04190j · Cited by 29
Chemical Biology Tools for Protein Lysine Acylation
Xie, Y., Du, S., Liu, Z., Liu, M., Xu, Z., Wang, X., Kee, J. X., Yi, F., Sun, H., & Yao, S. Q. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200303 · Cited by 29
Zanon, P. R. A., Lewald, L., & Hacker, S. M. (2019) · Angewandte Chemie · doi:10.1002/ange.201912075 · Cited by 29
Let-7i inhibition enhances progesterone-induced functional recovery in a mouse model of ischemia
Nguyen, T., Su, C., & Singh, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803384115 · Cited by 30
Rabalski, A. J., Bogdan, A. R., & Baranczak, A. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00424 · Cited by 30
PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discovery
Ma, H., Murray, J. B., Luo, H., Cheng, X., Chen, Q., Song, C., Duan, C., Tan, P., Zhang, L., Liu, J., et al. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00197g · Cited by 28
Ligand-binding pockets in RNA and where to find them
Veenbaas, S. D., Koehn, J. T., Irving, P. S., Lama, N. N., & Weeks, K. M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2422346122 · Cited by 31
Discovery of a Cell‐Active SuTEx Ligand of Prostaglandin Reductase 2
Toroitich, E. K., Ciancone, A. M., Hahm, H. S., Brodowski, S. M., Libby, A. H., & Hsu, K. (2021) · ChemBioChem · doi:10.1002/cbic.202000879 · Cited by 27
Developing Isoxazole as a Native Photo‐Cross‐Linker for Photoaffinity Labeling and Chemoproteomics
Cheng, K., Qi, J., Ren, X., Zhang, J., Li, H., Xiao, H., Wang, R. Y., Liu, Z., Meng, L., Ma, N., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202209947 · Cited by 27
Tonazzi, A., Giangregorio, N., Console, L., Palma, A. D., & Indiveri, C. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.04.002 · Cited by 27
CellFy: A Cell-Based Fragment Screen against C-Type Lectins
Schulze, J., Baukmann, H. A., Wawrzinek, R., Fuchsberger, F. F., Specker, E., Aretz, J., Nazaré, M., & Rademacher, C. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00875 · Cited by 27
Miyamoto, D. K., Flaxman, H. A., Wu, H., Gao, J., & Woo, C. M. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00511 · Cited by 27
Targeted and proteome-wide analysis of metabolite–protein interactions
Tsukidate, T., Li, Q., & Hang, H. C. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.008 · Cited by 28
Using Fragment-Based Approaches to Discover New Antibiotics
Lamoree, B., & Hubbard, R. E. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218773034 · Cited by 26
Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40
Tong, Y., Childs‐Disney, J. L., & Disney, M. D. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17308 · Cited by 25
Chemical diversity of reagents that modify RNA 2′-OH in water: a review
Shioi, R., & Kool, E. T. (2024) · Chemical Science · doi:10.1039/d4sc05317f · Cited by 25
Flaxman, H. A., Miyamoto, D. K., & Woo, C. M. (2019) · Current Protocols in Chemical Biology · doi:10.1002/cpch.75 · Cited by 27
Multimodal small-molecule screening for human prion protein binders
Reidenbach, A. G., Mesleh, M. F., Casalena, D. E., Vallabh, S. M., Dahlin, J. L., Leed, A., Chan, A. I., Usanov, D. L., Yehl, J., Lemke, C. T., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014905 · Cited by 26
Joining Forces: The Chemical Biology–Medicinal Chemistry Continuum
Plowright, A. T., Ottmann, C., Arkin, M. R., Auberson, Y. P., Timmerman, H., & Waldmann, H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.05.019 · Cited by 25
Liu, W., Zhang, Z., Zhang, Z., Hao, P., Ding, K., & Li, Z. (2019) · Chemical Communications · doi:10.1039/c8cc08753a · Cited by 25
Cheng, K., Lee, J., Hao, P., Yao, S. Q., Ding, K., & Li, Z. (2017) · Angewandte Chemie · doi:10.1002/ange.201709584 · Cited by 25
Howard, R. T., HEMSLEY, P. E., Petteruti, P., Saunders, C. N., Bermejo, J. A. M., Scott, J. S., Johannes, J. W., & Tate, E. W. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00963 · Cited by 24
Zhou, Y., Shen, W., Peng, J., Deng, Y., & Li, X. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116328 · Cited by 24
Guo, C., Chang, Y., Wang, X., Zhang, C., Hao, P., Ding, K., & Li, Z. (2018) · Chemical Communications · doi:10.1039/c8cc08685k · Cited by 24
Strategies to expand peptide functionality through hybridisation with a small molecule component
Wu, Y., Williams, J. P. C., Calder, E. D. D., & Walport, L. J. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00167h · Cited by 23
Wan, C., Yang, D., Song, C., Liang, M., An, Y., Lian, C., Dai, C., Ye, Y., Yin, F., Wang, R. Y., et al. (2024) · Chemical Science · doi:10.1039/d3sc05766f · Cited by 24
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–6
Eynde, J. J. V., Mangoni, A. A., Rautio, J., Leprince, J., Azuma, Y., García‐Sosa, A. T., Hulme, C., Jampílek, J., Karaman, R., Li, W., et al. (2019) · Molecules · doi:10.3390/molecules25010119 · Cited by 23
Inverse Drug Discovery identifies weak electrophiles affording protein conjugates
Kline, G. M., Nugroho, K., & Kelly, J. W. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.102113 · Cited by 22
Gibaut, Q. M. R., Bush, J. A., Tong, Y., Baisden, J. T., Taghavi, A., Olafson, H. R., Yao, X., Childs‐Disney, J. L., Wang, E. T., & Disney, M. D. (2023) · ACS Central Science · doi:10.1021/acscentsci.2c01223 · Cited by 24
Inhibition of Protein Secretion in Escherichia coli and Sub-MIC Effects of Arylomycin Antibiotics
Walsh, S. I., Peters, D. S., Smith, P. A., Craney, A. R., Dix, M. M., Cravatt, B. F., & Romesberg, F. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01253-18 · Cited by 22
Self-citationSecretome-Based Screening in Target Discovery
Ding, M., Tegel, H., Sivertsson, Å., Hober, S., Snijder, A., Ormö, M., Strömstedt, P.-E., Davies, R., & Schiavone, L. H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220917113 · Cited by 22
Pleiotropic Actions of PGRMC Proteins in Cancer
Pru, J. K. (2022) · Endocrinology · doi:10.1210/endocr/bqac078 · Cited by 22
A new light of proteomics in cell biology and toxicology
Qiao, T., & Wang, X. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09492-6 · Cited by 22
Burton, N. R., Polasky, D. A., Shikwana, F., Ofori, S., Yan, T., Geiszler, D. J., Veiga Leprevost, F. D., Nesvizhskii, A. I., & Backus, K. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c05797 · Cited by 22
Qiu, Y., Thomas, V., Fantoni, T., Chen, R., Jiang, X., He, Z., Butcher, T. W., Nomura, D. K., & Hartwig, J. F. (2024) · Chem · doi:10.1016/j.chempr.2024.08.024 · Cited by 21
Allosteric PROTACs: Expanding the Horizon of Targeted Protein Degradation
Frost, A. B., O’Connor, S., & Ciulli, A. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c14840 · Cited by 21
Pasquer, Q. T. L., Tsakoumagkos, I. A., & Hoogendoorn, S. (2020) · Molecules · doi:10.3390/molecules25235702 · Cited by 21
Seeing the forest through the trees: characterizing the glycoproteome
Critcher, M., Hassan, A. A., & Huang, M. L. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.02.007 · Cited by 21
HCovDock: an efficient docking method for modeling covalent protein–ligand interactions
Wu, Q., & Huang, S. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac559 · Cited by 21
Thomas, R. P., Grant, E. K., Dickinson, E. R., Zappacosta, F., Edwards, L. J., Hann, M. M., House, D., Tomkinson, N. C. O., & Bush, J. T. (2023) · RSC Medicinal Chemistry · doi:10.1039/d2md00453d · Cited by 22
Metadata
- Authors
- Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., & Cravatt, B. F.
- Affiliations
- Scripps Research Institute (US)
- École Polytechnique Fédérale de Lausanne (CH)
- Bristol-Myers Squibb (United States) (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Parker, Christopher G.
- Cravatt, Benjamin F.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 168
- Issue
- 3
- Pages
- 527-541.e29
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5632530
- OpenAlex
- W2575838842
- Cited by
- 439
- References
- 59
- Citations by year
- 2026: 29 · 2025: 44 · 2024: 42 · 2023: 49 · 2022: 55 · 2021: 50 · 2020: 49 · 2019: 52 · 2018: 39 · 2017: 29
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- American Cancer Society (PF-14-100-01-CDD)
- American Heart Association (14POST18200019)
- NIH (DK099810, CA132630, 1S10OD16357)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- fragment screening, chemical probes, protein-ligand interactions, human proteome, target identification, PGRMC2, adipogenesis, membrane proteins, site-specific binding, phenotypic screening, ligand discovery
- MeSH terms
- Cell Differentiation, Humans, Hydrolases, Ligands, Membrane Proteins, Oxidoreductases, Protein Binding, Receptors, Progesterone, Adipocytes, Crystallography, X-Ray, Proteomics, Small Molecule Libraries, Drug Discovery, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
